A Breakthrough Non-Invasive Diagnostic Test for Overactive Bladder (OAB)
Project: Other
- Dr John Young (PI)
- Sepinoud Firouzmand (CoI)
- Professor Anastasia Callaghan (CoI)
Description
This project is towards providing the initial proof-of-concept demonstration of an overactive bladder (OAB) biomarker detection platform. The resulting prototype biosensor detection platform will offer a step-change in providing a non-invasive and effective means of diagnosing OAB; allowing earlier, targeted treatment and symptom monitoring which together will benefit patients through improved outcomes. Specifically our objectives are to:
- Generate and validate separate biosensors for each of the biomarker molecules that make up our specific OAB fingerprint.
- Combine the separate biosensors into a single biosensor detection platform capable of simultaneously identifying the biomarker molecules of our OAB fingerprint.
- Validate the OAB biomarker detection platform using our biobank of clinically-characterised patient urine samples.
- Generate and validate separate biosensors for each of the biomarker molecules that make up our specific OAB fingerprint.
- Combine the separate biosensors into a single biosensor detection platform capable of simultaneously identifying the biomarker molecules of our OAB fingerprint.
- Validate the OAB biomarker detection platform using our biobank of clinically-characterised patient urine samples.
| Status | Finished |
|---|---|
| Effective start/end date | 1/09/18 → 29/02/20 |
Funding
- Rosetrees Trust: £115,000.00
- Rosetrees Trust: £29,754.00
Award relations
A Breakthrough Non-Invasive Diagnostic Test for Overactive Bladder (OAB)
Dr John Young, Firouzmand, S. & Professor Anastasia Callaghan
Rosetrees Trust: £29,754.00
1/09/18 → 29/02/20
Funding: R: Research › Award
Translation of a novel overactive bladder ‘fingerprint’ into a breakthrough non-invasive diagnostic test for use in a point of care setting.
Rosetrees Trust: £115,000.00
5/04/21 → 4/10/22
Funding: R: Research › Award
ID: 8641628
